Literature DB >> 11459446

Accounting for dropout bias using mixed-effects models.

C H Mallinckrodt1, W S Clark, S R David.   

Abstract

Treatment effects are often evaluated by comparing change over time in outcome measures. However, valid analyses of longitudinal data can be problematic when subjects discontinue (dropout) prior to completing the study. This study assessed the merits of likelihood-based repeated measures analyses (MMRM) compared with fixed-effects analysis of variance where missing values were imputed using the last observation carried forward approach (LOCF) in accounting for dropout bias. Comparisons were made in simulated data and in data from a randomized clinical trial. Subject dropout was introduced in the simulated data to generate ignorable and nonignorable missingness. Estimates of treatment group differences in mean change from baseline to endpoint from MMRM were, on average, markedly closer to the true value than estimates from LOCF in every scenario simulated. Standard errors and confidence intervals from MMRM accurately reflected the uncertainty of the estimates, whereas standard errors and confidence intervals from LOCF underestimated uncertainty.

Mesh:

Year:  2001        PMID: 11459446     DOI: 10.1081/BIP-100104194

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  89 in total

1.  Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome.

Authors:  Marcus A Rosencrantz; Mickey S Coffler; Annette Haggan; Kimberly B Duke; Michael C Donohue; Rana F Shayya; H Irene Su; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2011-01-26       Impact factor: 5.958

2.  Missing data in alcohol clinical trials: a comparison of methods.

Authors:  Kevin A Hallgren; Katie Witkiewitz
Journal:  Alcohol Clin Exp Res       Date:  2013-07-24       Impact factor: 3.455

Review 3.  Pragmatic randomised controlled trials in parenting research: the issue of intention to treat.

Authors:  Karen Whittaker; Chris Sutton; Chris Burton
Journal:  J Epidemiol Community Health       Date:  2006-10       Impact factor: 3.710

4.  Does analysis using "last observation carried forward" introduce bias in dementia research?

Authors:  Frank J Molnar; Brian Hutton; Dean Fergusson
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262

5.  Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.

Authors:  D Alan Lankford; Bruce C Corser; Yan-Ping Zheng; Zhengrong Li; Duane B Snavely; Christopher R Lines; Steve Deacon
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

6.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

7.  The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.

Authors:  Elbert S Huang; Michael O'Grady; Anirban Basu; Aaron Winn; Priya John; Joyce Lee; David Meltzer; Craig Kollman; Lori Laffel; William Tamborlane; Stuart Weinzimer; Tim Wysocki
Journal:  Diabetes Care       Date:  2010-03-23       Impact factor: 17.152

8.  Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Authors:  Kenneth A Holroyd; Constance K Cottrell; Francis J O'Donnell; Gary E Cordingley; Jana B Drew; Bruce W Carlson; Lina Himawan
Journal:  BMJ       Date:  2010-09-29

9.  Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.

Authors:  Frank J Molnar; Malcolm Man-Son-Hing; Brian Hutton; Dean A Fergusson
Journal:  Open Med       Date:  2009-03-24

10.  The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.

Authors:  A Prakash; R C Risser; C H Mallinckrodt
Journal:  Int J Clin Pract       Date:  2008-06-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.